CHARLIE’S HOLDINGS, INC.

CHUC ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2026 FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
Revenue $20.9M $7.8M $16.3M $26.4M $21.5M $16.7M $22.7M
Cost of Revenue $15.3M $4.9M $7.5M $10.1M
Gross Profit $5.7M $2.9M $9.2M $12.7M
Gross Margin 27.0% 37.1% 55.2% 55.7%
Operating Expenses
Research & Development $169.0K $804.0K $24.0K $3.4M $1.1M
SG&A Expense $6.4M $5.6M $7.0M $8.4M $8.8M $10.9M $15.0M
Operating Income $-2.2M $-3.3M $-2.2M $-1.8M $565.0K $-6.8M $-5.8M
Operating Margin -10.4% -42.5% -13.6% -6.8% 2.6% -40.6% -25.3%
Interest Expense $477.0K $155.0K $34.0K $134.0K $0
Pretax Income $4.6M $-4.0M $-2.1M $-1.7M $5.2M $-7.2M
Income Tax Expense $275.0K $0 $0 $-92.0K $342.0K $0 $29.0K
Net Income $4.5M $-4.2M $-2.1M $-1.6M $4.8M $-7.2M $-2.1M
Net Margin 21.5% -53.6% -12.9% -6.0% 22.4% -43.1% -9.4%
EPS (Basic) $0.02 $-0.02 $-0.01 $-0.01 $0.02 $-0.04 $0.00
EPS (Diluted) $0.02 $-0.02 $-0.01 $-0.01 $0.01 $-0.04 $0.00
Shares Outstanding (Basic) 274.2M 257.4M 234.8M 216.1M 212.3M 203.6M 189.8M 10.65B
Shares Outstanding (Diluted) 274.2M 278.5M 234.8M 216.1M 212.3M 237.7M 189.8M 10.65B
Dividends Per Share
← Newer Page 1 of 3 Older →